Gatekeepers and Enablers: How Drug Regulators Respond to a Challenging and Changing Environment by Moving Toward a Proactive Attitude

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|93|5|425-432

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.5, 2013-05, pp. : 425-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Accreditation Essentials: How Does Your Organization Respond to Adverse Drug Events?

By  

Joint Commission: The Source, Vol. 5, Iss. 1, 2007-01 ,pp. : 3-4

Joint Commission Resources

Access to resources Recommend Favorite

Preoperative Short-Course Radiotherapy in Locally Advanced Rectal Cancer: The Attitude on How to Use Radiotherapy in Rectal Cancer is Changing

By  

Oncology Research and Treatment, Vol. 31, Iss. 4, 2008-03 ,pp. : 165-165

Karger

Access to resources Recommend Favorite

Defining the Pharmaceutical System to Support Proactive Drug Safety

By  

Current Drug Safety, Vol. 8, Iss. 1, 2013-02 ,pp. : 25-39

Bentham Science Publishers

Access to resources Recommend Favorite

Moving from reactive to proactive care: the Welsh health agenda

By Davies Becki  

Community Practitioner, Vol. 78, Iss. 12, 2005-12 ,pp. : 423-424

Community Practitioner

Access to resources Recommend Favorite

How should we respond to cannabis‐impaired driving?

By  

DRUG AND ALCOHOL REVIEW, Vol. 37, Iss. 1, 2018-01 ,pp. : 3-5

John Wiley & Sons Inc

Access to resources Recommend Favorite